ReviewClinics in colon and rectal surgery2018
Gastrointestinal Stromal Tumors of the Distal Gastrointestinal Tract.
Review in Clinics in colon and rectal surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Adjuvant therapy for rare rectal gastrointestinal stromal tumors: A case report.Clinical case reports · 2024Article
- Digestive bleeding due to jejunal stromal tumor: A train can hide another-A case report.SAGE open medical case reports · 2024Article
- Anal canal gastrointestinal stromal tumour (GIST).BMJ case reports · 2023Article
- Imaging-Navigated Surgery.Advances in experimental medicine and biology · 2023Article
- A Low rectal GIST.BMJ case reports · 2022Article
- Review
- Colorectal Nonadenocarcinoma in South Korea.Annals of coloproctology · 2020Article
- Duodenojejunal intussusception secondary to primary gastrointestinal stromal tumor: A case report.International journal of surgery case reports · 2019Article
- Gastrointestinal stromal tumor with skeinoid fibers: an unusual presentation.Techniques in coloproctology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal stromal tumors (GISTs) are rare in occurrence, but comprise the most common mesenchymal tumors of the gastrointestinal tract and affect between 15 and 20 individuals per million per year. Due to recent advancements in molecular classification of these tumors, medical therapy has provided improved outcomes to a historically surgically managed disease. This review article briefly discusses the molecular characteristics, medical and surgical therapies, and future of GIST management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.